Phase II Trial of Temsirolimus in Patients with Relapsed or Refractory Multiple Myeloma

od Farag, Sherif S., Zhang, Shuhong, Jansak, Buffy S., Wang, Xiaojing, Kraut, Eric, Chan, Kenneth, Dancey, Janet E., Grever, Michael R.
Izdano 2009

Addition of Infliximab to Standard Acute Graft-versus-Host Disease Prophylaxis Following Allogeneic Peripheral Blood Cell Transplantation

od Hamadani, Mehdi, Hofmeister, Craig C., Jansak, Buffy, Phillips, Gary, Elder, Patrick, Blum, William, Penza, Sam, Lin, Thomas S., Klisovic, Rebecca, Marcucci, Guido, Farag, Sherif S., Devine, Steven M.
Izdano 2008

Standard Pentostatin Dose Reductions in Renal Insufficiency are not Adequate: Selected Patients with Steroid-Refractory Acute Graft-versus-Host Disease

od Poi, Ming J., Hofmeister, Craig C., Johnston, Jeffrey S., Edwards, Ryan B., Jansak, Buffy S., Lucas, David M., Farag, Sherif S., Dalton, James T., Devine, Steven M., Grever, Michael R., Phelps, Mitch A.
Izdano 2013